Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A11 | P48066 | 1/20 | 0.54 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 7/20 | 0.47 |
| ▸ | CA2 | P00918 | 7/20 | 0.47 |
| ▸ | CA7 | P43166 | 7/20 | 0.47 |
| ▸ | CA9 | Q16790 | 7/20 | 0.47 |
| ▸ | CA4 | P22748 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 1/20 | 0.46 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | ERN1 | O75460 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | PGR | P06401 | 2/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13211693 | 0.78 | CA1 (0.65) | CA1CA2CA7CA9CA4 | |
| SCHEMBL30512416 | 0.78 | SLC6A11 (0.61) | SLC6A11PDK2L3MBTL1ERN1KCNH2 | |
| SCHEMBL21580251 | 0.78 | SLC6A11 (0.61) | SLC6A11PDK2L3MBTL1ERN1KCNH2 | |
| SCHEMBL3026783 | 0.77 | CA1 (0.63) | CA1CA2CA7CA9CA4 | |
| SCHEMBL3022202 | 0.77 | CA1 (0.63) | CA1CA2CA7CA9CA4 | |
| SCHEMBL3025357 | 0.75 | CA1 (0.57) | CA1CA2CA7CA9CA4 | |
| SCHEMBL3022167 | 0.75 | CA1 (0.61) | CA1CA2CA7CA9CA4 | |
| SCHEMBL27554974 | 0.75 | SLC6A11 (0.58) | SLC6A11PDK2ALDH1A1TSHRMAPK1 | |
| SCHEMBL14027633 | 0.74 | CA1 (0.59) | PDK2CA1CA2CA7CA9 | |
| SCHEMBL4929877 | 0.73 | CA1 (0.41) | SLC6A11PDK2CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080248583-A1 | Quantitative and Qualitative Chelation Measuring Methods and Materials | ALBION LABORATORIES, INC. (US) | 2008-10-09 | — | — | US | claimed |
| WO-2006034195-A2 | QUANTITATIVE AND QUALITATIVE CHELATION MEASURING METHODS AND MATERIALS | ALBION LABORATORIES, INC. (US) | 2006-03-30 | — | — | WO | claimed |
| US-20080248583-A1 | Quantitative and Qualitative Chelation Measuring Methods and Materials | ALBION LABORATORIES, INC. (US) | 2008-10-09 | — | — | US | disclosed |
| US-20080248583-A1 | Quantitative and Qualitative Chelation Measuring Methods and Materials | ALBION LABORATORIES, INC. (US) | 2008-10-09 | — | — | US | disclosed |
| US-20080248583-A1 | Quantitative and Qualitative Chelation Measuring Methods and Materials | ALBION LABORATORIES, INC. (US) | 2008-10-09 | — | — | US | disclosed |
| WO-2006034195-A2 | QUANTITATIVE AND QUALITATIVE CHELATION MEASURING METHODS AND MATERIALS | ALBION LABORATORIES, INC. (US) | 2006-03-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080248583-A1 | Quantitative and Qualitative Chelation Measuring Methods and Materials | AAAS, LIG4, HAMP | SLC6A11 3433/4885PDK2 4452/4885CA1 1739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.